1. Search Result
Search Result
Results for "

CI 912-<sup>13</sup>C<sub>6</sub>

" in MedChemExpress (MCE) Product Catalog:
Targets Recommended:
Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-B0124S2

    AD 810-<sup>13sup>C<sub>6sub>; CI 912-<sup>13sup>C<sub>6sub>

    Isotope-Labeled Compounds Carbonic Anhydrase Apoptosis Neurological Disease
    Zonisamide- 13C6 (AD 810- 13C6) is 13C labeled Zonisamide. Zonisamide (AD 810) is an orally active carbonic anhydrase inhibitor, with Kis of 35.2 and 20.6 nM for hCA II and hCA V, respectively. Zonisamide exerts neuroprotective effects through anti-apoptosis and upregulating MnSOD levels. Zonisamide also increases the expression of Hrd1, thereby improving cardiac function in AAC rats. Zonisamide can be used in studies of seizure, parkinson’s disease and cardiac hypertrophy .
    Zonisamide-13C6